Abstract
Adenosine 5′ tetraphosphate, Ap4, is a natural nucleotide present in many biological systems. This nucleotide has been found as a constituent of the nucleotide pool present in the aqueous humor of New Zealand rabbits. HPLC analysis confirmed its identity and calculated its concentration levels to be 197 ± 21 nM. When applied topically to the rabbit eyes, this mononucleotide produced a reduction in the intraocular pressure, which was dose-dependent. The pD2 value calculated from the dose-response curve was 7.28 ± 0.47, which is equivalent to 52.48 nM. The time course of such intraocular pressure reduction presented a maximal decrease of IOP to 75.1 ± 2.3% compared with the vehicle control value (100%), and the effect lasted for more than 2 h. Cross-desensitization studies demonstrated that Ap4 effect was mediated via a P2X receptor in this system. P2 receptor antagonists suramin, pyridoxal phosphate 6-azophenyl-2′,4′-disulfonic acid (PPADS), and reactive blue 2 (RB-2) showed that only the latter was able to revert the effect of Ap4. Antagonists of adrenoceptors and cholinoceptors were able to partially reverse the effect of this nucleotide; this might indicate a connection with the neural mechanisms that control the intraocular pressure.
Footnotes
-
This work has been supported by a research grant from Inspire Pharmaceuticals, from the Ministry of Science and Technology DGCYT SAF2003-00338 and Fondos Europeos FEDER UCMA-E017.
-
DOI: 10.1124/jpet.103.058669.
-
ABBREVIATIONS: Ap4, adenosine 5′-tetraphosphate; IOP, intraocular pressure; Ap4A, diadenosine tetraphosphate; ATP-γ-S, adenosine 5′-3-O-thiotriphosphate; α,β-me ATP, α,β-methylene-adenosine 5′ triphosphate; β,γ-meATP, β,γ-methylene-adenosine 5′ triphosphate; HPLC, high-performance liquid chromatography; PPADS, pyridoxal phosphate 6-azophenyl-2′,4′-disulfonic acid; RB-2, reactive blue 2; Ap5A, diadenosine pentaphosphate; ICI-118.551, (±)-1-[2,3-(dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino].
- Received August 14, 2003.
- Accepted October 31, 2003.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|